Press releases

Non Regulatory

September 9, 2021

Nanoform technology delivers successful results for Herantis CDNF drug candidate

Non Regulatory

August 12, 2021

Invitation to presentation of Nanoform’s Q2/2021 report on August 26, 2021

Non Regulatory

August 3, 2021

Nanoform and Boehringer Ingelheim execute master services agreement

Non Regulatory

May 25, 2021

Nanoform and Celanese Explore Ways to Enhance Drug Delivery

Non Regulatory

May 18, 2021

Nanoform’s final clinical results confirm value proposition to the pharma industry

Non Regulatory

May 12, 2021

Invitation to presentation of Nanoform’s Q1/2021 report on May 27, 2021

Non Regulatory

April 21, 2021

Nanoform and Aprecia collaborate to advance 3D printed Nanomedicines

Non Regulatory

March 31, 2021

Nanoform and Nacuity Pharmaceuticals Sign Technology Proof of Concept (“PoC”) Agreement for Two Ophthalmic Drug Candidates

Non Regulatory

March 22, 2021

Nanoform launches next-generation STARMAP^® v2.0, the AI-based drug candidate selection tool for CESS^®

Non Regulatory

February 12, 2021

Invitation to presentation of Nanoform’s year-end report for 2020 on February 26, 2021

Non Regulatory

February 9, 2021

Nanoform and Herantis sign Biologics Proof of Concept Agreement

Non Regulatory

January 11, 2021

Finnish Foundation for Share Promotion and Nasdaq Helsinki has chosen Nanoform as the company of the month (article in Finnish)

Non Regulatory

December 23, 2020

Nanoform included in Nasdaq First North 25 index as of Jan 4th, 2021

Non Regulatory

December 21, 2020

First dosing of nanoformed drug successfully accomplished

Non Regulatory

December 8, 2020

Notification of major shareholdings according to Nanoform’s Articles of Association

Non Regulatory

December 2, 2020

Nanoform makes US TV debut in Advancements with Ted Danson (CNBC)

Non Regulatory

November 16, 2020

Invitation to presentation of Nanoform’s Q3 Report on November 27

Non Regulatory

November 11, 2020

Nanoform to present at Avanza Börsdag on November 18

Non Regulatory

September 1, 2020

Nanoform expands global commercial team with US appointments

Non Regulatory

July 9, 2020

Nanoform’s positive commercial momentum continues

Non Regulatory

June 15, 2020

Nanoform Finland Plc appoints Peter Hänninen as General Counsel

Non Regulatory

May 4, 2020

Nanoform awarded GMP certification

Non Regulatory

March 9, 2020

Nanoform and Orion collaborate on next-generation drug development

Non Regulatory

November 6, 2019

Nanoform wins the CPhI Excellence in Pharma Award for Formulation